BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17174555)

  • 1. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
    Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.
    Riemenschneider M; Konta L; Friedrich P; Schwarz S; Taddei K; Neff F; Padovani A; Kölsch H; Laws SM; Klopp N; Bickeböller H; Wagenpfeil S; Mueller JC; Rosenberger A; Diehl-Schmid J; Archetti S; Lautenschlager N; Borroni B; Müller U; Illig T; Heun R; Egensperger R; Schlegel J; Förstl H; Martins RN; Kurz A
    Hum Mol Genet; 2006 Aug; 15(16):2446-56. PubMed ID: 16825285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
    Xue S; Jia L; Jia J
    Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
    Miyashita A; Arai H; Asada T; Imagawa M; Matsubara E; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R;
    Hum Mol Genet; 2007 Dec; 16(23):2854-69. PubMed ID: 17761686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Cellini E; Guarnieri BM; Piacentini S; Sorbi S
    J Alzheimers Dis; 2009; 16(3):513-5. PubMed ID: 19276544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
    Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
    Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
    Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women.
    Fontalba A; Gutiérrez O; Llorca J; Mateo I; Berciano J; Fernández-Luna JL; Combarros O
    Dement Geriatr Cogn Disord; 2008; 26(3):247-50. PubMed ID: 18841008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF biomarkers in Alzheimer's disease and controls: associations with APOE genotype are modified by age.
    Kester MI; Blankenstein MA; Bouwman FH; van Elk EJ; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2009; 16(3):601-7. PubMed ID: 19276554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele.
    Riemenschneider M; Schwarz S; Wagenpfeil S; Diehl J; Müller U; Förstl H; Kurz A
    Mol Psychiatry; 2002; 7(7):782-5. PubMed ID: 12192623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
    Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
    J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.